-
-
-
-
-
-
A413769-100mgInformationAfuresertib (GSK2110183) is a potent, orally bioavailableAktinhibitor withKiof 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.TargetsAkt1 (Cell-free assay): Akt2 (Cell-free assay): Akt3 (Cell-free assay) 0.08
-
A413769-25mgInformationAfuresertib (GSK2110183) is a potent, orally bioavailableAktinhibitor withKiof 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.TargetsAkt1 (Cell-free assay): Akt2 (Cell-free assay): Akt3 (Cell-free assay) 0.08
-
A413769-5mgInformationAfuresertib (GSK2110183) is a potent, orally bioavailableAktinhibitor withKiof 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.TargetsAkt1 (Cell-free assay): Akt2 (Cell-free assay): Akt3 (Cell-free assay) 0.08
-
A288315-100mgSelective GnRH receptor antagonist.
-
A288315-10mgSelective GnRH receptor antagonist.
-
A288315-1mgSelective GnRH receptor antagonist.
-
A288315-25mgSelective GnRH receptor antagonist.